THE TREATMENT OF CANCER BY ISOLATION PERFUSION.
D000477:Alkylating Agents; D000900:Anti-Bacterial Agents; D000963:Antimetabolites; D000970:Antineoplastic Agents; D010478:Chemotherapy, Cancer, Regional Perfusion; D002699:Chlorambucil; D003520:Cyclophosphamide; D005472:Fluorouracil; D008466:Mechlorethamine; D008727:Methotrexate; D009369:Neoplasms / Q000628:therapy*; D009588:Nitrogen Mustard Compounds; D009729:Nursing; D013852:Thiotepa; D014116:Toxicology
D000477:Alkylating Agents; D000900:Anti-Bacterial Agents; D000963:Antimetabolites; D000970:Antineoplastic Agents; D009588:Nitrogen Mustard Compounds; D002699:Chlorambucil; D008466:Mechlorethamine; D003520:Cyclophosphamide; D013852:Thiotepa; D005472:Fluorouracil; D008727:Methotrexate
ALKYLATING AGENTS; ANTIBIOTICS; ANTIMETABOLITES; ANTINEOPLASTIC AGENTS; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; FLUOROURACIL; ISOLATION PERFUSION; MECHLORETHAMINE; METHOTREXATE; NEOPLASM THERAPY; NITROGEN MUSTARD COMPOUNDS; NURSING; THIO-TEPA; TOXICOLOGIC REPORT